Teladoc Health, Inc. Income Statement
TDOC / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Teladoc Health, Inc. reported $2.5B in revenue and $200M in net loss for FY2025. Revenue has grown at a 49.7% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.4B | $2.0B | $1.1B | - | $417.9M | $233.3M | $123.2M | $77.4M | $43.5M | $19.9M |
| Cost of Revenue | - | - | - | $744.0M | $650.3M | $390.8M | $184.5M | $128.7M | $61.6M | $32.0M | $21.0M | $9.9M | $4.2M |
| Gross Profit | - | - | - | - | - | - | - | $62.8M | $171.7M | $91.2M | $56.3M | $33.6M | $15.7M |
| SG&A Expense | $431.9M | $435.5M | $464.7M | $449.9M | $438.0M | $506.7M | $164.5M | $116.9M | $79.8M | $48.6M | $43.0M | $17.7M | $8.8M |
| R&D Expense | $277.9M | $307.3M | $348.5M | $333.6M | $311.9M | $164.9M | $64.6M | $54.4M | $34.5M | $21.8M | $14.2M | $7.6M | $3.5M |
| Operating Income | -$263.0M | -$1.0B | -$248.6M | -$13.7B | -$265.6M | -$506.4M | -$80.4M | -$70.9M | -$75.4M | -$62.7M | -$55.8M | -$15.2M | -$5.9M |
| Interest Expense | - | $23.8M | $22.3M | $21.9M | $81.1M | -$60.0M | -$29.4M | - | - | - | - | -$1.5M | -$56.0K |
| Income Tax | -$35.2M | $7.6M | $760.0K | -$3.8M | $44.1M | -$90.9M | -$10.6M | $118.0K | -$225.0K | $510.0K | $36.0K | $388.0K | $94.0K |
| Net Income | -$200.3M | -$1.0B | -$220.4M | -$13.7B | -$428.8M | -$485.1M | -$98.9M | -$97.1M | -$106.8M | -$74.2M | -$58.0M | -$17.0M | -$6.0M |
| EPS (Basic) | -$1.34 | -$84.60 | -$2.73 | -$5.36 | -$2.73 | -$5.36 | -$1.38 | - | - | - | - | - | - |
| EPS (Diluted) | -$1.34 | -$84.60 | -$2.73 | -$5.36 | -$2.73 | -$5.36 | -$1.38 | -$1.75 | -$2.91 | -$10.25 | -$8.05 | - | - |
| Shares Outstanding | 173.4M | 166.7M | 162.8M | 160.5M | 156.9M | 90.5M | 71.8M | 61.5M | 46.2M | 38.5M | 2.0M | 2.0M | 1.2M |
| Gross Margin | - | - | - | - | - | - | - | 15.0% | 73.6% | 74.0% | 72.8% | 77.2% | 79.0% |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | - | -17.0% | -32.3% | -50.9% | -72.1% | -34.8% | -29.5% |
| Profit Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | - | -23.2% | -45.8% | -60.3% | -75.0% | -39.1% | -30.2% |